Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.78p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.20
  • 52 Week Low: 0.68
  • Currency: UK Pounds
  • Shares Issued: 427.35m
  • Volume: 197,320
  • Market Cap: £3.31m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
60.47% below the market average60.47% below the market average60.47% below the market average60.47% below the market average60.47% below the market average
54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
35.71% above the market average35.71% above the market average35.71% above the market average35.71% above the market average35.71% above the market average
25.93% above the sector average25.93% above the sector average25.93% above the sector average25.93% above the sector average25.93% above the sector average
Price Book Ratio
22.32% below the market average22.32% below the market average22.32% below the market average22.32% below the market average22.32% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
72.78% below the market average72.78% below the market average72.78% below the market average72.78% below the market average72.78% below the market average
38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average
Price Chg 3m
40.58% below the market average40.58% below the market average40.58% below the market average40.58% below the market average40.58% below the market average
19.23% below the sector average19.23% below the sector average19.23% below the sector average19.23% below the sector average19.23% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI Not Available
Momentum 20 Not Available

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
90.2% below the market average90.2% below the market average90.2% below the market average90.2% below the market average90.2% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
51.42% below the market average51.42% below the market average51.42% below the market average51.42% below the market average51.42% below the market average
8.33% above the sector average8.33% above the sector average8.33% above the sector average8.33% above the sector average8.33% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
88.29% below the market average88.29% below the market average88.29% below the market average88.29% below the market average88.29% below the market average
70.59% below the sector average70.59% below the sector average70.59% below the sector average70.59% below the sector average70.59% below the sector average
Operating Profit Loss
64.58% below the market average64.58% below the market average64.58% below the market average64.58% below the market average64.58% below the market average
4.17% below the sector average4.17% below the sector average4.17% below the sector average4.17% below the sector average4.17% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
67.41% below the market average67.41% below the market average67.41% below the market average67.41% below the market average67.41% below the market average
39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average
Cash
47.12% below the market average47.12% below the market average47.12% below the market average47.12% below the market average47.12% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
24.92% below the market average24.92% below the market average24.92% below the market average24.92% below the market average24.92% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.78p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.20
52 Week Low 0.68
Volume 197,320
Shares Issued 427.35m
Market Cap £3.31m

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.52% below the market average31.52% below the market average31.52% below the market average31.52% below the market average31.52% below the market average
64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average
Price Trend
92.71% below the market average92.71% below the market average92.71% below the market average92.71% below the market average92.71% below the market average
88.46% below the sector average88.46% below the sector average88.46% below the sector average88.46% below the sector average88.46% below the sector average
Income Not Available
Growth
18.19% below the market average18.19% below the market average18.19% below the market average18.19% below the market average18.19% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Theracryf Dividends

No dividends found

Trades for 26-Jul-2024

Time Volume / Share Price
11:39 2,299 @ 0.75p
11:32 50,000 @ 0.79p
10:02 133,369 @ 0.78p
08:09 11,652 @ 0.75p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page